reported that spatial analysis in HNSCC identified interferon-induced MHC-IhiGal9+ CAFs, which create a trap for CD8+ T cells and lead to cancer immune evasion, could be promising targets for more effective immunotherapy for HNSCC (41). This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.